1. Jobsen JJ, ten Cate LN, Lybeert ML, van der Steen-Banasik EM, Scholten A, van der Palen J, et al. The number of metastatic sites for stage IIIA endometrial carcinoma, endometrioid cell type, is a strong negative prognostic factor. Gynecol Oncol. 2010; 117:32–6.
Article
2. Kato T, Watari H, Endo D, Mitamura T, Odagiri T, Konno Y, et al. New revised FIGO 2008 staging system for endometrial cancer produces better discrimination in survival compared with the 1988 staging system. J Surg Oncol. 2012; 106:938–41.
Article
3. Connell PP, Rotmensch J, Waggoner S, Mundt AJ. The significance of adnexal involvement in endometrial carcinoma. Gynecol Oncol. 1999; 74:74–9.
Article
4. Denschlag D, Tan L, Patel S, Kerim-Dikeni A, Souhami L, Gilbert L. Stage III endometrial cancer: preoperative predictability, prognostic factors, and treatment outcome. Am J Obstet Gynecol. 2007; 196:546.
Article
5. Lum MM, Belnap TW, Frandsen J, Brown AP, Sause WT, Soisson AP, et al. Survival analysis of cancer patients with FIGO stage IIIA endometrial cancer. Am J Clin Oncol. 2015; 38:283–8.
Article
6. Havrilesky LJ, Secord AA, O'Malley DM, Broadwater G, Bae-Jump V, Cohn DE, et al. Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer. Gynecol Oncol. 2009; 114:279–83.
Article
7. Lewin SN, Herzog TJ, Barrena Medel NI, Deutsch I, Burke WM, Sun X, et al. Comparative performance of the 2009 international Federation of gynecology and obstetrics' staging system for uterine corpus cancer. Obstet Gynecol. 2010; 116:1141–9.
Article
8. Choi EC, Kim JH, Kim OB, Byun SJ, Park SG, Kwon SH. Postoperative radiotherapy for endometrial cancer. Radiat Oncol J. 2012; 30:108–16.
Article
9. Schorge JO, Molpus KL, Goodman A, Nikrui N, Fuller AF Jr. The effect of postsurgical therapy on stage III endometrial carcinoma. Gynecol Oncol. 1996; 63:34–9.
Article
10. Kuku S, Williams M, McCormack M. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival: a single-institution retrospective study. Int J Gynecol Cancer. 2013; 23:1056–64.
11. Nakayama K, Nagai Y, Ishikawa M, Aoki Y, Miyazaki K. Concomitant postoperative radiation and chemotherapy following surgery was associated with improved overall survival in patients with FIGO stages III and IV endometrial cancer. Int J Clin Oncol. 2010; 15:440–6.
Article
12. Hogberg T, Signorelli M, de Oliveira CF, Fossati R, Lissoni AA, Sorbe B, et al. Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer: results from two randomised studies. Eur J Cancer. 2010; 46:2422–31.
13. Alvarez Secord A, Havrilesky LJ, Bae-Jump V, Chin J, Calingaert B, Bland A, et al. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer. Gynecol Oncol. 2007; 107:285–91.
14. Kuoppala T, Maenpaa J, Tomas E, Puistola U, Salmi T, Grenman S, et al. Surgically staged high-risk endometrial cancer: randomized study of adjuvant radiotherapy alone vs. sequential chemo-radiotherapy. Gynecol Oncol. 2008; 110:190–5.
Article
15. Mariani A, Webb MJ, Keeney GL, Aletti G, Podratz KC. Assessment of prognostic factors in stage IIIA endometrial cancer. Gynecol Oncol. 2002; 86:38–44.
Article
16. AlHilli MM, Mariani A, Bakkum-Gamez JN, Dowdy SC, Weaver AL, Peethambaram PP, et al. Risk-scoring models for individualized prediction of overall survival in low-grade and high-grade endometrial cancer. Gynecol Oncol. 2014; 133:485–93.
Article
17. Marchetti C, Pisano C, Mangili G, Lorusso D, Panici PB, Silvestro G, et al. Use of adjuvant therapy in patients with FIGO stage III endometrial carcinoma: a multicenter retrospective study. Oncology. 2011; 81:104–12.
Article
18. Jobsen JJ, Naudin Ten Cate L, Lybeert ML, Scholten A, van der Steen-Banasik EM, van der Palen J, et al. Outcome of endometrial cancer stage IIIA with adnexa or serosal involvement only. Obstet Gynecol Int. 2011; 2011:962518.
Article
19. Lan C, Huang X, Huang Y, Xi S, Huang H, Feng Y, et al. The outcome and efficacy of adjuvant chemotherapy alone in patients with stage IIIA endometrial carcinoma with solitary adnexal involvement: a retrospective single-institution study. Gynecol Oncol. 2014; 135:446–50.
Article
20. Ashman JB, Connell PP, Yamada D, Rotmensch J, Waggoner SE, Mundt AJ. Outcome of endometrial carcinoma patients with involvement of the uterine serosa. Gynecol Oncol. 2001; 82:338–43.
Article